Thus, the observed increased PCSK9 cerebrospinal fluid (CSF) concentrations in AD (Zimetti et al., 2017) may determine a higher turnover of LRP1 on different cell types, thus affecting the Aβ elimination via the BBB. This evidence concerns the gene LRP1 and Alzheimer disease.